Randomized Controlled Trial

Citations 1-10 of 86 total displayed.

Most recent content (1 Jun 2009):

Original Contributions
Effect of Changes in Fat Availability on Exercise Capacity in McArdle Disease

Susanne T. Andersen; Tina D. Jeppesen; Tanja Taivassalo; Marie-Louise Sveen; Katja Heinicke; Ronald G. Haller; John Vissing
Arch Neurol 2009; 66: 762-766. [Abstract] [Full text] [PDF]  

From JAMA
Enough Is Enough: Moving on to Deep Brain Stimulation in Patients With Fluctuating Parkinson Disease

Michael S. Okun; Kelly D. Foote
Arch Neurol 2009; 66: 778-780. [Extract] [Full text] [PDF]  

Past content (since Nov 1998):

Clinical Trials
Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease

Parkinson Study Group CALM Cohort Investigators
Arch Neurol 2009; 66: 563-570. [Abstract] [Full text] [PDF]  

From JAMA
Ginkgo biloba Prevention Trials: More Than an Ounce of Prevention Learned

Jeffrey Kaye
Arch Neurol 2009; 66: 652-654. [Extract] [Full text] [PDF]  

Original Contributions
Effect of Anti-CD25 Antibody Daclizumab in the Inhibition of Inflammation and Stabilization of Disease Progression in Multiple Sclerosis

Bibiana Bielekova; Thomas Howard; Amy N. Packer; Nancy Richert; Gregg Blevins; Joan Ohayon; Thomas A. Waldmann; Henry F. McFarland; Roland Martin
Arch Neurol 2009; 66: 483-489. [Abstract] [Full text] [PDF]  

Clinical Trials
Long-term Effect of Initiating Pramipexole vs Levodopa in Early Parkinson Disease

Parkinson Study Group CALM Cohort Investigators
Arch Neurol 2009.32. [Abstract] [Full text] []  

From JAMA
Exercised Against Dementia

Roger N. Rosenberg
Arch Neurol 2009; 66: 311-312. [Extract] [Full text] [PDF]  

Clinical Trials
Randomized Controlled Trial of Ethyl-Eicosapentaenoic Acid in Huntington Disease: The TREND-HD Study

Huntington Study Group TREND-HD Investigators
Arch Neurol 2008; 65: 1582-1589. [Abstract] [Full text] [PDF]  

Original Contributions
Sodium Oxybate for Excessive Daytime Sleepiness in Parkinson Disease: An Open-Label Polysomnographic Study

William G. Ondo; Thomas Perkins; Todd Swick; Keith L. Hull Jr; J. Ernesto Jimenez; Tippy S. Garris; Daniel Pardi
Arch Neurol 2008; 65: 1337-1340. [Abstract] [Full text] [PDF]  

Original Contributions
Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis

Chitra Krishnan; Adam I. Kaplin; Robert A. Brodsky; Daniel B. Drachman; Richard J. Jones; Dzung L. Pham; Nancy D. Richert; Carlos A. Pardo; David M. Yousem; Edward Hammond; Megan Quigg; Carrilin Trecker; Justin C. McArthur; Avindra Nath; Benjamin M. Greenberg; Peter A. Calabresi; Douglas A. Kerr
Arch Neurol 2008; 65: 1044-1051. [Abstract] [Full text] [PDF]  

[Next page] Pages: 1 2 3 4 5 6 7 8 9